Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis
Status:
Terminated
Trial end date:
2020-12-18
Target enrollment:
Participant gender:
Summary
This is a phase 1, single-center, first-in-human study to assess the safety, pharmacokinetics
and pharmacodynamics of DS-2741a after subcutaneous injection in healthy Japanese male
volunteers and Japanese participants with moderate to severe atopic dermatitis.